We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As part of the FDA’s pharmaceutical cGMP initiative, the agency has announced it will release a multicenter analysis of internal and international current good manufacturing practices (cGMP) requirements, as well as a draft guidance on modern quality systems.